Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
13 Cards in this Set
- Front
- Back
MOA of INH
|
structural cogener of B6 (pyridoxine), inhibits mycolic acids (compenents of mycobacterial cell walls)
|
|
what TB drug is usually given for prophylaxis of TB
|
INH
|
|
neurotoxic effects of INH can be elieviated by adminitering what?
|
B6 (pyridoxine)
|
|
what genetic disorder is associated with hemolysis when taking INH?
|
pts w/ glucose-6-phosphate dehydrogenase deffiency
|
|
MOA of rifampin
|
inhibition of DNA-dependant RNA polymerase
|
|
major SE of rifampin
|
induction of drug metabolizing liver enzymes, increasing the elimination of anticonvulsants, contraceptives, cyclosporine, ketoconazole, methadone, terbinafine, and warfarin
|
|
MOA of ethambutol
|
inhibition of arabinosyl transferase (arabinogalactan is a component of the mycobaterial cell wall)
|
|
SE of ethambutol
|
visual disturbances
|
|
SE of pyrazinamide
|
polyarthralgia, porphyria, hepatic dysfuntion, should not be used in pregnancy
|
|
drug Tx for TB when INH resistance is suspected
|
rifampin + pyrazinamide + ethambutol or streptomycin
|
|
multi drug resistant TB can be treated with what drugs (based on susceptability)
|
amikacin, ciprofloxacin, ofloxacin, ethionamide, p-aminosalicylic acid (rarely)
|
|
usual drug Tx for M. leprae
|
Dapsone, rifampin and clofazimine combination
|
|
prophylaxis of MAC in AIDS pts w/ CD4 <50
|
clarythromycin or azithromycin with or without rifabutin
|